ANTI-CD19 CARS ARMED WITH NK RECEPTOR-DERIVED ACTIVATION DOMAINS DEMONSTRATE TO IMPROVE CAR-NK ANTITUMOR EFFECTOR FUNCTION AND ARE DIFFERENTIALLY ENHANCED BY DASATINIB

Autor: Santos, MHD, Azevedo, JTC, Silvestre, RN, Calado, RDT, Covas, DT, Picanç-Castro, V
Zdroj: In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S517-S518
Databáze: ScienceDirect